| Register
| Log out
Submit An Article

ASX: MDR

Latest Articles

  • MedAdvisor’s PlusOne platform wins Queensland healthcare pilot contract

    MedAdvisor’s PlusOne platform wins Queensland healthcare pilot contract

    Covid-19 reimagined the world’s approach to healthcare. While it put excessive strain on healthcare employees, it urged companies and governments to think outside the box and develop a more sustainable system for the post-pandemic world. Of course, that looked different for everyone.  For countries like Estonia and the US, it entailed boosting telehealth services. For

    Read More
    Public
  • MedAdvisor engaged with $4m deal to promote COVID-19 vaccination

    MedAdvisor engaged with $4m deal to promote COVID-19 vaccination

    While Australia enjoys the freedom of restrictions opening up and a substantial decrease in the COVID-19 deaths, vaccination rates across various States in the US remain dangerously low which has prompted one big pharma company to engage medtech company MedAdvisor (ASX: MDR) to slay the anti-vaxxers.  For the unnamed big pharma company which has a

    Read More
    Public
  • Major U.S healthcare company invests $11m in MedAdvisor at a premium

    Major U.S healthcare company invests $11m in MedAdvisor at a premium

    Australian medtech company MedAdvisor (ASX: MDR) has received a major boost in confidence following an oversubscribed capital raise which included an $11m investment from U.S healthcare solutions provider HMS (NASDAQ: HMSY).  The investment from HMS comes alongside a further $6m raised from institutional investors bringing their total funds raised to $17m, all at an Offer

    Read More
    Public

Login or register for free to access unlimited reading

Register Now!

The content published on this website is solely for general information purposes and is not to be construed as financial advice. Should you seek financial advice you should consult with an appropriately qualified person. Opinions expressed on this site are subject to change without notice and The Sentiment who produced this content is under no obligation to keep the information current. The Sentiment, affiliated companies & associates may have a conflict of interest with companies discussed on the website due to commercial arrangements, for example they may be shareholders in the company, be engaged by them to assist in investor communications or receive commission/brokerage for funds raised.

Copyright © 2020 The Sentiment. All rights reserved.